PMS-LIDOCAINE VISCOUS 2% LIQUID

Land: Kanada

Språk: engelska

Källa: Health Canada

Köp det nu

Produktens egenskaper Produktens egenskaper (SPC)
07-04-2016

Aktiva substanser:

LIDOCAINE HYDROCHLORIDE

Tillgänglig från:

PHARMASCIENCE INC

ATC-kod:

N01BB02

INN (International namn):

LIDOCAINE

Dos:

2%

Läkemedelsform:

LIQUID

Sammansättning:

LIDOCAINE HYDROCHLORIDE 2%

Administreringssätt:

DENTAL

Enheter i paketet:

100,50 ML

Receptbelagda typ:

OTC

Terapiområde:

LOCAL ANESTHETICS

Produktsammanfattning:

Active ingredient group (AIG) number: 0101280001; AHFS:

Bemyndigande status:

MARKETED

Tillstånd datum:

1990-12-31

Produktens egenskaper

                                PRESCRIBING INFORMATION
PMS-LIDOCAINE VISCOUS 2%
Lidocaine Hydrochloride Oral Topical Solution, USP
20 mg/mL
Oral Topical Anesthetic
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
www.pharmascience.com
Date of Revision:
April 6, 2016
Submission Control No: 193450
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 2 of 21 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................11
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................16
REFERENCES
..................................................................................................................17
PART III: CONSUMER
INFORMATION...............................................................................18
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 3 of 21 _
_ _
PMS-LIDOCAINE VISCOUS 
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Produktens egenskaper Produktens egenskaper franska 15-04-2016

Sök varningar relaterade till denna produkt